There are likely very complex relationships also occurring between various Cannabinoids in Cannabis that may lead to certain medical efficacy. That is important to remember when considering the consumption of products that contain Cannabinoids. There is an attractiveness to isolating a specific chemical, researching it, patenting synthetic derivatives, and marketing specific drugs. That said, the relationships are complex, will likely take years to understand, and many patients I’ve met appear to find the most medical benefit from a diverse group of Cannabinoids whose interactions are not particularly well understand, but the results are hard to argue with.
Endoca’s CBD products are sourced from the highest quality organically grown hemp. From seed to shelf, they oversee their entire US operation and have been awarded by the UN for their sustainable farming and manufacturing processes.  In addition to the primary ingredients, this product also includes omega-3, vitamin E and omega-6. There are also low concentrations of essential compounds from the hemp plant. The capsules do not contain any artificial colors, preservatives, GMOs or gluten. They are kosher, gluten-free and vegan.
The current trend in the cannabis-related area of research started in the late sixties and early seventies when products derived from cannabis (especially marijuana) were placed on the list of controlled substances in the US, under the Nixon administration. This move was retroactively interpreted as being part of the conservative reaction to the liberalizing spirit of the sixties. 

While this should by no means be taken as direct clinical evidence that CBD for weight loss is a tried-and-true remedy for obesity, the studies mentioned above should certainly warrant more investigation into the topic. And to be sure, many folks are already using CBD products to help control their appetite and lose weight. Do a little research online for customer feedback and reviews, and you’ll see what we mean.
As revealed by the results of a study published by the Addiction Journal and performed by University College London, smokers wishing to quit and treated with one 800mg dose of CBD, saw 40 percent more success in the first week of their attempt when using CBD products, than those treated with a placebo. Those treated with even a low dose of CBD claimed fewer intrusive thoughts, enabling them to go about their daily lives without the need for a cigarette, unlike those who were not given the cannabinoid. (6)

Correcting a calorie excess with a calorie deficit sometimes works for weight loss, but it can be difficult. First of all, reducing calories leaves people feeling hungry, which can be incredibly uncomfortable. Second of all, weight gain can cause changes to hormone levels and balance, metabolic patterns, inflammation status, and balance within the endocannabinoid system.

Our bodies are thought to produce endocannabinoids by the billions every day. “We always thought the ‘runner’s high’ was due to the release of dopamine and endorphins. But now we know the euphoria is also from an endocannabinoid called anandamide,” its name derived from the Sanskrit word for bliss, says Joseph Maroon, MD, clinical professor and vice chairman of neurosurgery at the University of Pittsburgh Medical Center. We produce these natural chemicals all day, but they fade quickly because enzymes pop up to destroy them. That’s where CBD comes in: By blocking these enzymes, CBD allows the beneficial compounds to linger.

The immediate and powerful effects of THC are explained because of the special affinity it has with the CB1 type receptors, which mediate crucial processes in the brain. The less prominent (but no less important) action of CBD was explained, at least for a while, by hypothesizing that it binds to CB2 type receptors, hence its more diffuse manner of exercising changes in the body. Early on, the antipsychotic effects of cannabidiol were observed, an aspect which seemed to be in consonance with this initial hypothesis.


This turn is due to a comprehensive 2015 study aimed at two notoriously difficult manifestations of epilepsy – Dravet syndrome and Lennox-Gastaut syndrome – most often encountered in children. Seizure frequency was found to decrease between 54 percent and 67 percent for the six months cannabidiol medication was used, although a small part of individuals did not continue after three months, as their condition did not improve.
Due to the uniqueness of everyone’s endocannabinoid system, CBD does not affect any two people the same way. There are a host of factors that influence its efficacy, including genetics, previous history of use, general health, weight, ethnicity and so on. Therefore, while one person may find that 15 mg of CBD a day works wonders for suppressing appetite and boosting weight loss, another may require up to 100 mg (or more) in order to achieve the same results (in fact, they may not experience any results at all).
People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].
The previously mentioned study which established improved mitochondrial function with CBD use also observed that CBD stimulates gene expression within white fat cells. This initiates the “browning” of these cells. This mechanism shows promise with converting hard-to-lose white fat into a more easily burnable form. Additionally, researchers found that CBD decreased the rate of new fat cell creation.
Moreover, Murray Mittleman, an associate professor of medicine at Harvard Medical School, explained to Time Magazine in 2013 that weed users had lower fasting insulin levels and were less resistant to insulin produced by the body. He was referring to research from the National Health and Nutrition Examination Survey, which analyzed 4,600 men and women over a five year period from 2005 to 2010. 48% of them used marijuana at least once in their lives, and 12% were current weed users.
Current studies, including one carried out by the UC San Diego School of Medicine, are looking into how the endocannabinoid system may be linked to reducing symptoms associated with autism. This is due to its role in social reward responsivity, neural development and circadian rhythm and anxiety regulation – all of which are often affected by autism. (52)
×